Cisplatin or ImmunoTHerapy in Association With Definitive Radiotherapy in HPV-related oropharyngEal Squamous Cell Carcinoma: a Randomized Phase II Trial.

Condition:   Oropharyngeal Squamous Cell Carcinoma
Interventions:   Drug: Chemoradiotherapy arm;   Drug: Immunotherapy + Radiotherapy arm
Sponsors:   Institut Claudius Regaud;   AstraZeneca
Not yet recruiting

https://ift.tt/2OpN3gE